BAJAJ BROKING

Notification close image
No new Notification messages
card image
Euro Pratik Sales Ltd IPO
Apply for the Euro Pratik Sales Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

544220

CTLLAB

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Clinitech Laboratory Limited Share Price Update

As of the latest trading session, Clinitech Laboratory Limited share price is currently at ₹ 46.04, which is up by ₹ 0.00 from its previous closing. Today, the stock has fluctuated between ₹ 46.04 and ₹ 46.50. Over the past year, Clinitech Laboratory Limited has achieved a return of -44.72 %. In the last month alone, the return has been -4.40 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Clinitech Laboratory Limited fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    10.50

  • P/E Ratio (TTM)

    26.61

  • Beta

    0.43

  • Book Value / share

    38.68

  • Return on equity

    5.49%

  • EPS (TTM)

    1.52

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text

Clinitech Laboratory Limited Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 8.23
Operating Expense 7.90
Net Profit 0.39
Net Profit Margin (%) 4.73
Earnings Per Share (EPS) 1.90
EBITDA 1.06
Effective Tax Rate (%) 29.09
Particulars MAR 2024 (Values in Cr)
Revenue 6.40
Operating Expense 5.93
Net Profit 0.37
Net Profit Margin (%) 5.78
Earnings Per Share (EPS) 2.37
EBITDA 1.04
Effective Tax Rate (%) 25.49
Particulars MAR 2023 (Values in Cr)
Revenue 6.35
Operating Expense 5.50
Net Profit 0.61
Net Profit Margin (%) 9.60
Earnings Per Share (EPS) 4.09
EBITDA 1.36
Effective Tax Rate (%) 29.06
Particulars MAR 2022 (Values in Cr)
Revenue 6.38
Operating Expense 5.76
Net Profit 0.51
Net Profit Margin (%) 7.99
Earnings Per Share (EPS) 3.42
EBITDA 1.14
Effective Tax Rate (%) 27.14
Particulars MAR 2021 (Values in Cr)
Revenue 4.55
Operating Expense 4.06
Net Profit 0.40
Net Profit Margin (%) 8.79
Earnings Per Share (EPS) 6.04
EBITDA 0.88
Effective Tax Rate (%) 25.45
Particulars MAR 2025 (Values in Cr)
Book Value / Share 38.69
ROE % 5.49
ROCE % 7.92
Total Debt to Total Equity 0.07
EBITDA Margin 12.03
Particulars MAR 2024 (Values in Cr)
Book Value / Share 21.12
ROE % 12.48
ROCE % 12.25
Total Debt to Total Equity 0.32
EBITDA Margin 16.09
Particulars MAR 2023 (Values in Cr)
Book Value / Share 15.87
ROE % 28.84
ROCE % 23.60
Total Debt to Total Equity 0.45
EBITDA Margin 21.73
Particulars MAR 2022 (Values in Cr)
Book Value / Share 12.32
ROE % 31.48
ROCE % 31.15
Total Debt to Total Equity 0.44
EBITDA Margin 17.87
Particulars MAR 2021 (Values in Cr)
Book Value / Share 20.86
ROE % 28.78
ROCE % 30.69
Total Debt to Total Equity 0.38
EBITDA Margin 19.12
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 3.07
Total Assets 10.71
Total Liabilities 10.71
Total Equity 8.83
Share Outstanding 2282400
Price to Book Ratio 1.04
Return on Assets (%) 3.68
Return on Capital (%) 4.47
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.70
Total Assets 5.60
Total Liabilities 5.60
Total Equity 3.54
Share Outstanding 1680000
Price to Book Ratio 0.00
Return on Assets (%) 6.61
Return on Capital (%) 8.41
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.78
Total Assets 6.03
Total Liabilities 6.03
Total Equity 2.38
Share Outstanding 1500000
Price to Book Ratio 0.00
Return on Assets (%) 10.16
Return on Capital (%) 17.98
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.10
Total Assets 3.68
Total Liabilities 3.68
Total Equity 1.84
Share Outstanding 1500000
Price to Book Ratio 0.00
Return on Assets (%) 13.90
Return on Capital (%) 18.75
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.32
Total Assets 2.73
Total Liabilities 2.73
Total Equity 1.39
Share Outstanding 666666
Price to Book Ratio 0.00
Return on Assets (%) 14.72
Return on Capital (%) 20.88
Particulars MAR 2025 (Values in Cr)
Net Income 0.55
Cash from Operations -0.71
Cash from Investing -0.72
Cash from Financing 3.98
Net change in Cash 2.37
Free Cash Flow 0.44
Particulars MAR 2024 (Values in Cr)
Net Income 0.50
Cash from Operations -1.13
Cash from Investing 0.75
Cash from Financing 0.44
Net change in Cash -0.08
Free Cash Flow 0.06
Particulars MAR 2023 (Values in Cr)
Net Income 0.86
Cash from Operations 1.54
Cash from Investing -0.65
Cash from Financing 0.08
Net change in Cash 0.67
Free Cash Flow 1.82
Particulars MAR 2022 (Values in Cr)
Net Income 0.70
Cash from Operations 1.16
Cash from Investing -1.46
Cash from Financing 0.29
Net change in Cash -0.21
Free Cash Flow 2.67
Particulars MAR 2021 (Values in Cr)
Net Income 0.54
Cash from Operations 0.53
Cash from Investing 0.54
Cash from Financing -0.87
Net change in Cash 0.04
Free Cash Flow 0.71
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7815.85 71.42 13.69 112379.93 6002.15 / 7981.20
FORTIS MALAR HOSPITALS LIMITED 65.20 26.50 4.04 122.20 51.01 / 98.70
SHREE PACETRONIX LTD. 203.60 70.21 5.31 73.28 61.11 / 203.60
TRANSGENE BIOTEK LTD. 4.02 0.00 3.03 30.46 3.22 / 8.55
VIMTA LABS LIMITED 793.85 58.16 10.31 3535.87 254.43 / 902.85
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7815.85 83.16 12.86 112379.93 6002.15 / 7981.20
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 38.10 0.00 -15.05 28.46 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 6309.30 31.31 6.35 6902.37 4777.15 / 6525.00

Clinitech Laboratory Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
46.04 0.00 redarrow
red-green-graph indicator
1 Bearish
15 Bullish
  • 5 Days 48.10
  • 26 Days 46.90
  • 10 Days 49.00
  • 50 Days 46.10
  • 12 Days 48.90
  • 100 Days 51.90
  • 20 Days 47.80
  • 200 Days 63.50
46.19 PIVOT

First Support

45.89

First Resistance

46.35

Second Support

45.73

Second Resistance

46.65

Third Support

45.43

Third Resistance

46.81

RSI

48.61

ADX

55.66

MACD

2.02

Williams % R

-94.97

Commodity Channel Index (CCI)

-83.74

Date

2025-09-15

Week

4200.00

Same Day

2400.00

Month

6933.00

1 Year

0.43

3 Year

0.58

Over 1 Month

-4.40%

down

Over 1 Year

-44.72%

down

Over 3 Months

15.09%

down

Over 3 Years

0.00%

down

Over 6 Months

8.22%

down

Over 5 Years

0.00%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

Clinitech Laboratory Limited shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
38.1%
Promoter Holdings
61.57%
FII
0.31%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Jyoti Jagdish Nayak 675000.0 (29.57%) Shareholding of Promoter and Promoter Group
Jagdish Umakant Nayak 674500.0 (29.55%) Shareholding of Promoter and Promoter Group
Santosh Gopalkrishna Kudva 141600.0 (6.2%) Public Shareholding
Vishal Ashok Talreja 74400.0 (3.26%) Public Shareholding
Siddhesh Anant Nayak 55500.0 (2.43%) Shareholding of Promoter and Promoter Group
Ajit Sakharam Kandar 51200.0 (2.24%) Public Shareholding
Mukesh Thumar 26600.0 (1.17%) Public Shareholding
Sanjay Harshadrai Mehta 26400.0 (1.16%) Public Shareholding
Ananya Jagdish Nayak 100.0 (0.0%) Shareholding of Promoter and Promoter Group
Eshwari Anant Nayak 100.0 (0.0%) Shareholding of Promoter and Promoter Group
Ashutosh Jagdish Nayak 100.0 (0.0%) Shareholding of Promoter and Promoter Group
Anant Umakant Nayak 100.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

Clinitech Laboratory Limited corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Clinitech Laboratory Limited Share Price

Clinitech Laboratory Limited was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 with the Registrar of Companies, Mumbai. The status of Company was changed to Public Limited and the name of Company changed to Clinitech Laboratory Limited through fresh certificate of incorporation upon conversion on August 25, 2023 was issued by the Registrar of Companies, Mumbai.

Clinitech Laboratory are a provider of diagnostic and healthcare tests and services through chain of 8 diagnostic centers in and around Thane, Raigad and Navi Mumbai. Their Promoters have 30+ years of experience in diagnostic business. Promoters inspirational leadership has led Clinitech to be recognised as one of the trusted pathology lab in the region. They conduct more than 3 Lakh tests per year in NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited labs equipped with modern technology and high-end equipment.

The Company established a new Lab in Kalyan in 2012, NABL Accreditation at Airoli Centre in 2016, a new Lab at Thane in 2018. Besides these, the Company conduct more than 150 tests including Biochemistry, Immunology, Hematology, Molecular Biology tests, urine analysis, Serology, Microbiology and Histopathology tests. Clinical pathology is a medical specialty that focuses on the diagnosis of diseases and conditions through the analysis of bodily fluids and tissues. It includes various laboratory tests and techniques such as blood tests, urine analysis, and tissue biopsies to help healthcare professionals understand the underlying causes of a patient's symptoms and guide treatment decisions.

Clinical pathologists play a crucial role in interpreting test results and providing valuable information to aid in patient care. Imaging diagnosis or radiology involves imaging procedures such as X-rays and ultrasounds that help determine anatomical or physiological changes inside a patient's body, thus assisting doctors in diagnosing. It includes more complex tests such as CT scans, MRIs, and highly specialized PET-CT scans.

The Company is proposing the Initial Offering by raising capital aggregating Rs 5.79 Crores and by issuing 6,02,400 Fresh Issue Equity Shares.

Parent organization Indian Private
NSE symbol [-]
Founded 2010
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Clinitech Laboratory Ltd?

Answer Field

Clinitech Laboratory Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 46.04 as on Sep 15 2025 12:00 AM.

What is the Market Cap of Clinitech Laboratory Ltd Share?

Answer Field

The market cap of Clinitech Laboratory Ltd for NSE ₹ 0.00 & for BSE ₹ 10.50 as on Sep 15 2025 12:00 AM.

What is the 52 Week High and Low of Clinitech Laboratory Ltd?

Answer Field

The 52 Week High and Low of Clinitech Laboratory Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 98.99 and ₹ 29.15.

What is 1 year return for Clinitech Laboratory Ltd?

Answer Field

The 1 year returns on the stock has been -44.72%.

What is the P/E Ratio of Clinitech Laboratory Ltd Share?

Answer Field

As on Sep 15 2025 12:00 AM the price-to-earnings (PE) ratio for Clinitech Laboratory Ltd share is 26.61.

What is the PB ratio of Clinitech Laboratory Ltd Share?

Answer Field

As on Sep 15 2025 12:00 AM, the price-to-book (PB) ratio for Clinitech Laboratory Ltd share is 38.68.

How to Buy Clinitech Laboratory Ltd Share?

Answer Field

You can trade in Clinitech Laboratory Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Clinitech Laboratory Ltd Share on Bajaj Broking App?

Answer Field

To buy Clinitech Laboratory Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Clinitech Laboratory Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91